• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013 年至 2040 年间 184 个国家按来源分列的卫生支出。

National spending on health by source for 184 countries between 2013 and 2040.

机构信息

Institute for Heath Metrics and Evaluation, Seattle, WA, USA.

Institute for Heath Metrics and Evaluation, Seattle, WA, USA.

出版信息

Lancet. 2016 Jun 18;387(10037):2521-35. doi: 10.1016/S0140-6736(16)30167-2. Epub 2016 Apr 13.

DOI:10.1016/S0140-6736(16)30167-2
PMID:27086174
Abstract

BACKGROUND

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at similar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected.

METHODS

We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks.

FINDINGS

Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42-22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9-3·4) in high-income countries, 3·4% (2·4-4·2) in upper-middle-income countries, 3·0% (2·3-3·6) in lower-middle-income countries, and 2·4% (1·6-3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending.

INTERPRETATION

Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action.

FUNDING

Bill & Melinda Gates Foundation.

摘要

背景

人们普遍认为,随着一个国家经济的发展,人均卫生支出会增加,通过政府或私人机制预付的卫生支出份额也会增加。然而,即使在发展水平相似的情况下,这些变化的速度和幅度在各国之间也有很大差异。在这项研究中,我们利用过去的趋势和关系来估计未来的卫生支出,按资金来源对其进行细分,以确定如果当前政策和趋势按预期发展,可能出现的融资轨迹。

方法

我们从世卫组织卫生支出观察站和健康计量与评估研究所的《2015 年全球卫生筹资》报告中提取数据。我们将这些数据转换为采用相同购买力平价和经通胀调整的货币。我们使用一系列集成模型和观察到的经验规范来估计未来政府自付的私人预付款和卫生发展援助支出。我们将每个国家的估计值汇总,以生成 184 个国家 2013 年至 2040 年的总卫生支出。我们将这些估计值与彼此以及国际公认的基准进行了比较。

结果

预计全球卫生支出将从 2013 年的 7.83 万亿美元增加到 2040 年的 18.28 万亿美元(不确定区间为 14.42-22.24 万亿美元)(按 2010 年购买力平价调整后的美元计算)。我们预计,高收入国家的人均卫生支出每年将增长 2.7%(1.9-3.4),中上收入国家将增长 3.4%(2.4-4.2),中下收入国家将增长 3.0%(2.3-3.6),低收入国家将增长 2.4%(1.6-3.1)。鉴于当前卫生支出存在差距,这些增长率表明卫生支出的均等化程度没有提高。在 1995 年和 2015 年,即使经过购买力调整,低收入国家的卫生支出也仅为高收入国家的三分之一,预计到 2040 年仍将如此。最重要的是,许多低收入国家的卫生支出预计仍将保持较低水平。估计表明,到 2040 年,只有 34 个低收入国家中的 1 个(3%)和 98 个中等收入国家中的 36 个(37%)将达到国际设定的政府卫生支出占国内生产总值 5%的目标。

解释

尽管取得了显著的健康进步,但过去的卫生筹资趋势和关系表明,许多低收入和中低收入国家将无法实现国际设定的卫生支出目标,除非采取实质性的政策干预措施,否则低收入国家和高收入国家之间的支出差距不太可能缩小。尽管提高卫生系统效率可以取得进展,但目前的趋势表明,需要采取协调一致的行动才能增加有意义的卫生系统资源。

资金来源

比尔及梅琳达·盖茨基金会。

相似文献

1
National spending on health by source for 184 countries between 2013 and 2040.2013 年至 2040 年间 184 个国家按来源分列的卫生支出。
Lancet. 2016 Jun 18;387(10037):2521-35. doi: 10.1016/S0140-6736(16)30167-2. Epub 2016 Apr 13.
2
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.全球卫生融资的过去、现在和未来:对 195 个国家 1995 年至 2050 年用于卫生的发展援助、政府、自付费用和其他私人支出的评估。
Lancet. 2019 Jun 1;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4. Epub 2019 Apr 25.
3
Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.2015-2040 年的卫生未来和潜在支出:卫生发展援助,以及 184 个国家的政府、预付款私人和自费卫生支出。
Lancet. 2017 May 20;389(10083):2005-2030. doi: 10.1016/S0140-6736(17)30873-5. Epub 2017 Apr 19.
4
Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.卫生与艾滋病毒/艾滋病支出:1995-2015 年 188 个国家的国内卫生支出和发展援助。
Lancet. 2018 May 5;391(10132):1799-1829. doi: 10.1016/S0140-6736(18)30698-6. Epub 2018 Apr 17.
5
Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.1995-2014 年全球卫生筹资的演变和格局:184 个国家的卫生发展援助、政府、预付款私人和自费卫生支出。
Lancet. 2017 May 20;389(10083):1981-2004. doi: 10.1016/S0140-6736(17)30874-7. Epub 2017 Apr 19.
6
Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.追踪卫生和 COVID-19 方面的发展援助:对 204 个国家和地区 1990-2050 年的卫生方面的发展援助、政府、自付费用和其他私人支出的审查。
Lancet. 2021 Oct 9;398(10308):1317-1343. doi: 10.1016/S0140-6736(21)01258-7. Epub 2021 Sep 22.
7
Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40.未来卫生筹资和覆盖范围趋势:188 个国家 2016-40 年未来卫生支出和全民健康覆盖
Lancet. 2018 May 5;391(10132):1783-1798. doi: 10.1016/S0140-6736(18)30697-4. Epub 2018 Apr 17.
8
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.卫生部门支出以及在艾滋病毒/艾滋病、结核病和疟疾方面的支出和用于卫生的发展援助:在实现可持续发展目标 3 方面的进展。
Lancet. 2020;396(10252):693-724. doi: 10.1016/S0140-6736(20)30608-5. Epub 2020 Apr 23.
9
Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000-17: a financial modelling study.追踪 135 个低收入和中等收入国家 2000-17 年按来源和功能划分的结核病总支出:一项财务建模研究。
Lancet Infect Dis. 2020 Aug;20(8):929-942. doi: 10.1016/S1473-3099(20)30124-9. Epub 2020 Apr 23.
10
Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.估算 2000-2017 年低收入和中等收入国家常规和补充免疫活动的资金来源总支出:一项金融模型研究。
Lancet. 2021 Nov 20;398(10314):1875-1893. doi: 10.1016/S0140-6736(21)01591-9. Epub 2021 Nov 4.

引用本文的文献

1
Evaluating the impact of the diagnosis-related groups payment system on laparoscopic uterine fibroid surgery outcomes: insights from a single-center study.评估诊断相关分组支付系统对腹腔镜子宫肌瘤手术结局的影响:来自一项单中心研究的见解
Front Public Health. 2025 Jun 10;13:1555444. doi: 10.3389/fpubh.2025.1555444. eCollection 2025.
2
Exploring facilitators and barriers in the financial model of hospitals: a qualitative case study on prehabilitation from the Netherlands.探索医院财务模式中的促进因素和障碍:一项来自荷兰的术前康复定性案例研究。
BMJ Open. 2025 Jun 16;15(6):e095154. doi: 10.1136/bmjopen-2024-095154.
3
The impact of an innovative payment model on the direct economic burden of infectious disease inpatients: evidence from a pilot City in central China.
创新支付模式对传染病住院患者直接经济负担的影响:来自中国中部一个试点城市的证据。
Int J Equity Health. 2025 May 26;24(1):150. doi: 10.1186/s12939-025-02531-1.
4
Cost-effectiveness analysis of FOLFOXIRI/FOLFOXIRI and mFOLFOX6/FOLFIRI treatment in first-line and second-line chemotherapy for metastatic colorectal cancer.FOLFOXIRI/FOLFOXIRI与mFOLFOX6/FOLFIRI用于转移性结直肠癌一线和二线化疗的成本效益分析
BMJ Open. 2025 Mar 24;15(3):e086372. doi: 10.1136/bmjopen-2024-086372.
5
Global prevalence of cannabis and amphetamine/methamphetamine use among adolescents in 47 countries: a population-based study from WHO database.47个国家青少年使用大麻和苯丙胺/甲基苯丙胺的全球流行率:一项基于世界卫生组织数据库的人群研究。
World J Pediatr. 2025 Mar;21(3):291-305. doi: 10.1007/s12519-025-00883-w. Epub 2025 Mar 20.
6
Using microdata as a basis for long term projections of hospital care spending: the added value of more detailed information.利用微观数据作为医院护理支出长期预测的基础:更详细信息的附加价值。
Health Econ Rev. 2025 Mar 19;15(1):25. doi: 10.1186/s13561-025-00607-w.
7
Quality-of-care indicators for oncology management: an analysis of Asia-Pacific healthcare and oncology indicators.肿瘤管理的医疗质量指标:亚太地区医疗保健与肿瘤指标分析
ESMO Open. 2025 Mar;10(3):104293. doi: 10.1016/j.esmoop.2025.104293. Epub 2025 Mar 7.
8
Hidden costs of surgical complications: a retrospective cohort study.手术并发症的隐性成本:一项回顾性队列研究。
BMJ Surg Interv Health Technol. 2025 Mar 3;7(1):e000323. doi: 10.1136/bmjsit-2024-000323. eCollection 2025.
9
Cost-effectiveness analysis of daratumumab plus bortezomib, melphalan and prednisone versus bortezomib, melphalan and prednisone in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation.达雷妥尤单抗联合硼替佐米、美法仑和泼尼松与硼替佐米、美法仑和泼尼松用于不适于干细胞移植的新诊断多发性骨髓瘤患者的成本效益分析
BMJ Open. 2025 Feb 19;15(2):e076914. doi: 10.1136/bmjopen-2023-076914.
10
Facilitating Informal Support Among Older People Through Community-Based Initiatives: Identifying Underlying Mechanisms.通过社区倡议促进老年人的非正式支持:识别潜在机制。
Gerontologist. 2025 May 10;65(6). doi: 10.1093/geront/gnaf070.